AI
MIST icon

Atria Investments’s Milestone Pharmaceuticals MIST Stock Holding History

Atria Investments’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38,666
Closed -$91.3K – 1967
2024
Q4 		$91.3K Sell
38,666
-1,755
-4% -$3.01K ﹤0.01% 1836
2024
Q3 		$61.4K Buy
40,421
+12,430
+44% +$18.1K ﹤0.01% 1884
2024
Q2 		$36.9K Buy
+27,991
New +$45K ﹤0.01% 1897

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Atria Investments's MIST Position: Q1 2025 in Review

Atria Investments sold out of Milestone Pharmaceuticals (MIST) in Q1 2025, closing a stake of 38,666 shares — an estimated $91.3K sold.

Atria Investments first reported a position in MIST in Q2 2024 and held it in 3 quarters. The position peaked at $91.3K in Q4 2024. 43 funds tracked by Wall St. Rank hold MIST as of Q1 2025.

  • Atria Investments reported no remaining Milestone Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Atria Investments sold 38,666 Milestone Pharmaceuticals shares in Q1 2025, an estimated $91.3K.
  • Atria Investments first reported a position in Milestone Pharmaceuticals in Q2 2024 and held it in 3 quarters.
  • Atria Investments's Milestone Pharmaceuticals position peaked at $91.3K in Q4 2024.
  • 43 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2025.

Based on Atria Investments's 13F filing for Q1 2025, filed 6 May 2025.